The US Humira biosimilar market, when it finally launched in January 2023, attracted seven distinct biosimilar manufacturers within the first six months
Primary research Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights
Maintaining a stable, cool environment ensures that the molecular binding affinity remains completely uncompromised over the duration of a lengthy study, ensuring data fidelity remains exceptionally high across all experimental testing phases
Other important considerations: Semaglutide is not a lifetime drug for weight loss
Figures 912), tendon (Figure 12), ligament, and bone (Figure 13) (Sikiric et al., 1993
Newcrom R1 is a special reverse-phase column with low silanol activity